Actineer, a joint venture between Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE (ITM), today ...

Blue Earth Therapeutics, a clinical-stage radiopharmaceutical company and University College London (UCL) today announced ...

Actinium's cyclotron produced Actinium-225 material has demonstrated radiochemical and radionuclidic purity identical to current gold-standard methods and has the potential to be significantly lower ...

CHALK RIVER, Ontario--(BUSINESS WIRE)--Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has successfully produced Actinium-225 (Ac-225) by irradiating Radium-226 ...

Pantai Hospital Kuala Lumpur nuclear medicine specialist Dr Wong Teck Huat says Actinium-225 has the potential to effectively treat cancer without inflicting as much damage to the body as compared to ...

The domestic production base for Actinium (Ac-225), which is essential for prostate cancer treatment, has been established. On the 22nd, the Ministry of Science and ICT held a field meeting at the ...

Thanks to a recent upgrade to the medical isotope facilities at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, actinium-225 (Ac-225), an isotope that shows great promise for ...

Niowave has entered into a new agreement with Novartis to supply Actinium-225, a highly promising medical isotope The long-term supply agreement supports the development of next-generation therapies ...